2.872EUR-2.64%Mkt Cap: 314.14M $P/E: —Today
Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and g…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap314.14M $
Enterprise Value140.05M $
Revenue (TTM)69.37M $
Gross Profit68.64M $
Net Income (TTM)-73.47M $
Revenue/Share0.6902 USD
Last Price2.872 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees224
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0010425595
Valuation
P/E (Trailing)—
P/E (Forward)-1.87
PEG—
EV/EBITDA-2.76
EV/Revenue2.02
P/S4.67
P/B6.06
EPS (TTM)-0.56
EPS (Forward)-1.58
52W Range
2.03030% of range4.840
52W High4.840 EUR
52W Low2.030 EUR
Profitability
Gross Margin86.57%
Oper. Margin-340.69%
EBITDA Margin-73.13%
Profit Margin-92.66%
ROE-89.05%
ROA-20.82%
Growth
Revenue Growth-62.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-42.83M $
CapEx (TTM)3.84M $
FCF Margin168.75%
FCF Yield37.27%
Net Debt-93.84M $
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity1.20
Current Ratio1.37
Quick Ratio1.34
Book Value/Sh0.4881 EUR
Cash/Share2.293 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.500 EUR
Upside (mean)+126.3%
Target Range6.500 EUR – 6.500 EUR
# Analysts1
Ownership
Shares Out.72.70M
Float46.79M
Insiders48.01%
Institutions10.42%
Technical
SMA 502.573 (+11.6%)
SMA 2003.241 (-11.4%)
Beta2.75
S&P 52W Chg18.16%
Avg Vol (30d)117.41K
Avg Vol (10d)119.90K
Technical Indicators
RSI (14)65.6
MACD0.0539
MACD Signal0.0037
MACD Hist.+0.0502
BB Upper2.854 EUR
BB Middle2.574 EUR
BB Lower2.294 EUR
BB Width21.79%
ATR (14)0.1400 EUR
Vol Ratio (20d)3.33x